Echocardiographic evaluation of mitral stenosis

Similar documents
Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Quantification of Mitral Stenosis: Planimetry, pressure Half time, Continuity Common Errors

Balloon mitral valvuloplasty

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

MITRAL STENOSIS. Joanne Cusack

Mitral Valve Stenosis: What do I need to know? ACC Latin American Conference 2017

Prosthetic valve dysfunction: stenosis or regurgitation

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

Congenital. Unicuspid Bicuspid Quadricuspid

HEMODYNAMIC ASSESSMENT

Quantification of Aortic Regurgitation

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Tricuspid and Pulmonary Valve Disease

When Does 3D Echo Make A Difference?

Disclosures Rebecca T. Hahn, MD, FASE

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Aortic Stenosis: LVOT Obstruction

TAVR: Echo Measurements Pre, Post And Intra Procedure

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

13/06/2018. Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment. Mitral Stenosis ESC Guidance 2017

How to assess ischaemic MR?

MITRAL REGURGITATION ECHO PARAMETERS TOOL

25 different brand names >44 different models Sizes mm

Comprehensive Echo Assessment of Aortic Stenosis

Back to Basics: Common Errors In Quantitation In Everyday Practice

Valve Disease Board Review Questions

Organic mitral regurgitation

What echo measurements are key prior to MitraClip?

ECHOCARDIOGRAPHY DATA REPORT FORM

Aortic stenosis aetiology: morphology of calcific AS,

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation

LUST trial. Echocardiography USER S MANUAL

Tricuspid and Pulmonary Valve Disease

Stress Testing in Valvular Disease

Primary Mitral Regurgitation

Doppler Basic & Hemodynamic Calculations

Revealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane

Workshop Facing the challenge of TAVI 2016

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Quantification of MR

Swan Song: Echocardiography as a Pulmonary Artery Catheter? Interdepartmental Division of Critical Care Medicine

8/31/2016. Mitraclip in Matthew Johnson, MD

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

Choose the grading of diastolic function in 82 yo woman

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Blank DISCLOSURES 1/17/2017 COMPLEX VALVE CASES CHALLENGES IN EVALUATING AND MANAGING MULTIVALVULAR HEART DISEASE ECHO HAWAII 1/23/17 NONE

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

Echocardiographic Evaluation of Mitral Valve Prostheses

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

The Patient with Atrial Fibrilation

Percutaneous Therapy for Calcific Mitral Valve Disease

Quantifying Aortic Regurgitation

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

ASCeXAM / ReASCE. Practice Board Exam Questions Monday Morning

Prognostic Value of Left Atrial Size and Function

What are the best diagnostic tools to quantify aortic regurgitation?

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

Learn and LiveSM. ACC/AHA Pocket Guideline. Based on the ACC/AHA 2006 Guideline Revision. Management of Patients With. Valvular Heart Disease

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Pitfalls and how to avoid them

Three-dimensional echocardiography in the clinical world

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Section 1: Initial Evaluation for Valvular Heart Disease Table 1: Initial Evaluation of an Asymptomatic Patient

British Society of Echocardiography

Management of TR in Patients Undergoing Mitral Interventions

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Diastolic Heart Failure

Right Heart Hemodynamics: Echo-Cath Discrepancies

Advanced Applica,on of Point- of- Care Echocardiography in Cri,cal Care. Dr. Mark Tutschka Dr. Rob ArnAield

How to Assess Diastolic Dysfunction?

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

Indicator Mild Moderate Severe

Diastolic Function Assessment Practical Ways to Incorporate into Every Echo

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

The V Wave. January, 2007 Joe M. Moody, Jr, MD UTHSCSA and ALMMVAH. Ref: Kern MJ. Hemodynamic Rounds, 2 nd ed

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

Diastolic Heart Function: Applying the New Guidelines Case Studies

Low Gradient Severe? AS

Percutaneous Mitral Valve Repair

Recommendations of the European Association of Echocardiography

Transcription:

Echocardiographic evaluation of mitral stenosis Euroecho 2011 Philippe Unger, MD, FESC Erasme Hospital, ULB, Brussels, Belgium

I have nothing to declare

EuroHeart Survey Etiology of single native left-sided valve disease 100% 80% 60% 40% 20% 0% AS n=1197 AR n=369 MS n=336 MR n=877 Other Ischemic Congenital Inflamatory Endocarditis Rheumatic Degenerative Eur Heart J 2003 Jul;24(13):1231-43

Typical M-mode and 2D echocardiographic features of rheumatic MS

Degenerative MS

Echocardiographic differential diagnosis of LV inflow obstruction LV diastolic dysfunction Rheumatic Degenerative/Calcific Congenital Carcinoid heart disease SLE Rheumatoid arthritis Hunter-Hurler Fabry disease Whipple disease Methysergide therapy Myxoma Thrombus Cor triatriatum

Echocardiographic evaluation of the patient with MS MS severity Pressure gradient Valve area Exercise Presence and severity of coexisting MR Mitral valve anatomy LA thrombus? (before PBV) LA, LV, RV size and function Pulmonary systolic pressures (Rheumatic) involvement of other valves?

Pressure gradient: simplified Bernoulli equation ΔP=4v² Mean gradient 18 mm Hg Nishimura RA et al. J Am Coll Cardiol 1994;24:&(é

Pitfalls in evaluation of MS severity Pressure gradient Intercept angle between MS jet and ultrasound beam Beat-to-beat variability in AF Dependence on transvalvular volume flow rate and on diastolic filling period exercise, infection, pregnancy, coexisting MR

Relation between pressure gradient and mitral valve area: Role of transmitral diastolic flow rate Gradient 1.0 cm² Increasing severity 1.5 cm² 2.0 cm² Flow

Planimetry Reference method Faletra F, et al. J Am Coll Cardiol 1996;28:1190

Pitfalls: Image orientation and tomographic plane MVA 1.1 cm² MVA 1.5 cm²

Pitfalls: 2D gain settings 1.05 cm² 0.72 cm²

Pitfalls Poor acoustic access, severe distortion of valve anatomy, severe ca++ on leaflet tips Feasibility in the elderly? r = 0.39 Shaw TR, et al. Heart 2003;89:1430

Pressure half-time method Moderate MS Severe MS LV LA

Pressure half-time method MVA = 220/PHT Peak PG Peak V Peak PG/2 Peak V/1.4 Hatle et al. Circulation 1979

Accuracy of Doppler PHT method in assessing severity of MS in patients with and without prior commissurotomy Unoperated patients (N=37) Previous commissurotomy (11.2±5.4 yrs before) (N=37) Smihth MD, et al. Circulation 1986;73:100

Pitfalls in PHT-derived valve area calculation LV compliance/relaxation/pressure Coexisting moderate-to-severe AR MS severity Immediately after commissurotomy In the elderly (AHT, associated AS) LA compliance

Pitfalls of PHT method Curvilinear slope Atrial Fibrillation

Pitfalls of PHT method E/A fusion Carotid Sinus Massage HR 85 bpm Mean gradient 17 mm Hg HR 73 bpm Mean gradient 10 mm Hg

Pitfalls of PHT method Lutembacher syndrome MS+ASD

Proximal Isovelocity Surface Area (PISA) Method MVA = 2Π(r²)(V aliasing )/Peak V mitral Rodriguez L et al. Circulation 1993;88:1157

1. Zoom on the flow convergence

2. Aliasing velocity 20-30 cm/s

3. Measure the radius of the flow convergence and the transmitral velocity

4. Measure the angle formed by the mitral leaflets MVA = (2 r²) x aliasv / maxv x /180 LV LA = 90 = 180

4. Measure the angle formed by the mitral leaflets MVA = (2 r²) x aliasv / maxv x /180 LV LA = 100 = 100

5. Apply the formula MVA = R². 2. aliasv/v max. /180 MVA = (1.71)². 6.28. 25 /252. 10/180 = 1.01 cm²

MVA assessed by the PISA method using a fixed correction angle of 100 versus MVA measured by the PISA method with the exact angle measured using a protractor r=0.97, P<0.0001 MVA = (2 r²) x aliasv / maxv x 100/180 Messika-Zeitoun D et al. Eur J Echocardiogr 2007;8:116-121

MVA assessed by the PISA method using a fixed angle correction of 100 versus planimetry r=0.91, P<0.0001 MVA = (2 r²) x aliasv / maxv x 100/180 Messika-Zeitoun D et al. Eur J Echocardiogr 2007;8:116-121

The continuity equation Mitral stroke volume = Aortic stroke volume X = X Mitral valve area Mitral TVI LVOT diameter LVOT TVI

Continuity equation: Caveats Inaccuracy of LVOT diameter determination (Π.r²) Caution if AF, as mitral and aortic stroke volumes are calculated from different beats Invalidated by aortic or mitral regurgitation

AR MR MVA = LVOT diameter X LVOT TVI Mitral TVI Understimates severity Overstimates severity

Diagnostic caveats in patients with multivalve lesions Unger P et al. Heart 2011;97:272-277

70 y-o woman Severe HF LVOT VTI 21.2 cm LVOT diam 1.7 cm SV 48 ml SVI 30 ml/m²

Max V 3.60 m/s Mean PG: 32 mm Hg Ao VTI: 96 cm AVA: 0.5 cm² Catheterization: AVA 0.6 cm² Low flow low gradient AS

Mean PG: 8 mm Hg Mi VTI: 52 cm PHT: 90 ms MVA (PHT): 2.4 cm² MVA (continuity): 0.92 cm² R=1.1 cm (alias 31 cm) Max V 2.1 m/s MVA (PISA) 1.12 cm² Catheterization: MVA 1.04 cm² Low flow low gradient MS

Low flow low gradient MS Low flow low gradient AS

Pressure gradient Planimetry (2D) PHT Level 1 EAE/ASE Recommendation appropriate and recommended for all patients Continuity equation PISA Level 2 EAE/ASE Recommendation reasonnable when additional informations are needed in selected patients

What about 3D echocardiography?

Real-time 3D color-defined planimetry using TTE in calcific MS N = 34 mean age 72 ± 13 years Chu JW, et al. J Am Soc Echocardiogr 2008;21:1006

Real-time 3D transthoracic echocardiography Chu JW, et al. J Am Soc Echocardiogr 2008;21:1006

Real-time 3D transesophageal echocardiography

Real-time 3D TEE Schlosshan D et al. JACC Cardiovasc Imaging. 2011 Jun;4(6):580-8.

3D-TEE Planimetry MV leaflet tips using the short-axis view determined after multiplanar reconstruction Schlosshan D, et al. JACC Img 2011 Jun;4(6):580-8.

3D TEE versus other techniques Feasibility Mean difference vs other techniques (cm²) % 100 90 80 70 60 50 40 30 20 10 0 3D Continuity 2D PHT Feasibility 0,05 0-0,05-0,1-0,15-0,2-0,25 P< 0.005 P< 0.0001 P= 0.82 2D PHT cont N=43 Intraclass correlation coefficient interobs 0.93; intraobs 0.96 Schlosshan D, et al. JACC Img 2011 Jun;4(6):580-8.

Correlation between MVA measured using 2D-TTE and real-time 3D-TEE measured by an experienced operator (upper panel) and by a non-experienced operator (lower panel) Experienced operator Non-experienced operator Dreyfus J et al. Eur J Echocardiogr 2011;12:750-755

Role of TEE? When acoustic windows are poor using TTE Percutaneous mitral commissurotomy To exclude LA or LAA thrombus Occasionally performed during MBV to guide transseptal puncture or position of a balloon.

Conclusions Evaluation of MS should determine Its severity Its suitability for PMC Strengths, pitfalls and limitations of each method of severity assessement should be known The decision-making process should also include Associated valve lesions Pulmonary pressure Age Heart rhythm NYHA class Predicted operative mortality

Thank you for your attention!

Recommendations for classification of MS severity Specific findings Mild Moderate Severe Valve area (cm²) >1.5 1.0-1.5 <1.0 Supportive findings < 1 cm²/m² Mean gradient (mm Hg)* <5 5-10 >10 Pulmonary artery pressure (mm Hg) <30 30-50 >50 *At heart rate 60-80 bpm and in sinus rhythm Baumgartner H et al. Eur J Echocardiogr 2009;10:1

The echo examination in MS: ACC/AHA guidelines 2006 Pressure gradient Hemodynamic severity MVA TTE (TEE) Class I, Level B PAP Valve morphology Suitability for PMBV TTE Class I, Level B If discrepency between resting Doppler echo, clinical findings, symptoms and signs Mean gradient MVA Exercise TTE Class I, Level C LA thrombus Suitability for PMBV TEE Class I, Level C Co-existing MR Evaluation of severity TTE (TEE) Class I, Level C Routine evaluation of MV morphology and hemodynamics when TTE satisfactory TEE Class III

Images Displaying Different Views of the MV Commissure Using 3DTEE Schlosshan D, et al. JACC Img 2011 Jun;4(6):580-8.

(A) RT3D view of a rheumatic mitral valve. Pérez de Isla L et al. Eur J Echocardiogr 2007;8:470-473 Copyright 2007, The European Society of Cardiology